GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Danimer Scientific Inc (NYSE:DNMR) » Definitions » Revenue

Danimer Scientific (Danimer Scientific) Revenue : $46.68 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Danimer Scientific Revenue?

Danimer Scientific's revenue for the three months ended in Dec. 2023 was $10.95 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $46.68 Mil. Danimer Scientific's Revenue per Share for the three months ended in Dec. 2023 was $0.11. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.46.

Warning Sign:

Danimer Scientific Inc revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of Danimer Scientific was -12.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was -34.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 5 years, Danimer Scientific's highest 3-Year average Revenue per Share Growth Rate was 11.70% per year. The lowest was -34.10% per year. And the median was -11.20% per year.


Danimer Scientific Revenue Historical Data

The historical data trend for Danimer Scientific's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Danimer Scientific Revenue Chart

Danimer Scientific Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
32.34 47.33 58.75 53.22 46.68

Danimer Scientific Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.32 11.93 12.87 10.95 10.95

Competitive Comparison of Danimer Scientific's Revenue

For the Specialty Chemicals subindustry, Danimer Scientific's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Danimer Scientific's Revenue Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Danimer Scientific's Revenue distribution charts can be found below:

* The bar in red indicates where Danimer Scientific's Revenue falls into.



Danimer Scientific Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $46.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Danimer Scientific  (NYSE:DNMR) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Danimer Scientific Revenue Related Terms

Thank you for viewing the detailed overview of Danimer Scientific's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Danimer Scientific (Danimer Scientific) Business Description

Traded in Other Exchanges
Address
140 Industrial Boulevard, Bainbridge, GA, USA, 39817
Danimer Scientific Inc creates more sustainable, more natural ways to make plastic products sold under the proprietary Nodax brand name. The company's renewable and sustainable biopolymers have helped create plastic products that are 100% biodegradable and compostable. Danimer Scientific's products return to nature instead of polluting lands and waters. Its technology can be found in a vast array of plastic end-use products that people use every day. Applications for its biopolymers include additives, aqueous coatings, fibers, filaments, films, and injection-molded articles, among others. The company holds more than 470 patents and pending patent applications in nearly 20 countries for a range of manufacturing processes and biopolymer formulations.
Executives
Richard J Hendrix director 1300 NORTH 17TH STREET, ARLINGTON VA 22209
Scott Tuten officer: Chief Marketing Officer 286 DOE RUN DRIVE, CAIRO GA 39828
Gregory W. Hunt director 730 5TH AVENUE, NEW YORK NY 10019
Allison Leopold Tilley director 1300 NORTH 17TH STREET, ARLINGTON VA 22209
Cynthia R Cohen director 1401 BRICKELL AVENUE, SUITE 640, C/O STRATEGIC MINDSHARE, MIAMI FL 33131
John P Amboian director
Michael A Hajost officer: Chief Financial Officer C/O CARPENTER TECHNOLOGY CORPORATION, PO BOX 14662, READING PA 19612-4662
Stephen Croskrey director, officer: CEO & Chairman of the Board C/O ARMOR HOLDINGS INC, 1400 MARSH LANDING PARKWAY SUITE 112, JACKSONVILLE FL 32250
Stuart W Pratt director 303 CONGRESS STREET, BOSTON MA 02210
Van Trump Phillip D officer: Chief Technology Officer 1466 NORTH DECATUR ROAD, ATLANTA GA 30306
Philip Gregory Calhoun director 2100 WHITES BRIDGE ROAD, COLQUITT GA 39837
Isao Noda director 1568 HUNTER ROAD, FAIRFIELD OH 45914
Michael Eric Smith officer: Chief Operating Officer 2208 WYNDHAM WAY, BAINBRIDGE GA 39819
Christy A Basco director 206 WINDING HOLLOW LANE, COPPELL TX 75019
Wunderlich Gary Kent Jr 10 percent owner, officer: President, other: President CLO B. RILEY FINANCIAL, INC.,, 21255 BURBANK BLVD., SUITE 400, WOODLAND CA 91367